Rani Therapeutics Holdings, Inc. (RANI) Share-based Payment Arrangement, Expense USD 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Rani Therapeutics Holdings, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
  • Rani Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $4.5 M, a 42.1% increase year-over-year.
  • Rani Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $15.8 M, a 30.2% decline year-over-year.
  • Rani Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19 M, a 20.4% increase from 2022.
  • Rani Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.8 M, a 30.2% decline from 2021.
  • Rani Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $22.6 M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $19 M +$3.23 M +20.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-20
2022 $15.8 M -$6.81 M -30.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-20
2021 $22.6 M +$22.6 M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.